We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
+7.36%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$27.9B
AUM Growth
+$2.56B
(+10%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
4.85%
Top 10 Holdings %
Top 10 Hldgs %
20.25%
Holding
944
New
47
Increased
467
Reduced
283
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$199M |
| 2 |
Apple
AAPL
|
+$125M |
| 3 |
Plug Power
PLUG
|
+$112M |
| 4 |
UnitedHealth
UNH
|
+$90.4M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$82.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$114M |
| 2 |
Generac Holdings
GNRC
|
+$95.5M |
| 3 |
Bank of America
BAC
|
+$70.1M |
| 4 |
NVIDIA
NVDA
|
+$68.4M |
| 5 |
CSX Corp
CSX
|
+$63.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.79% |
| 2 | Healthcare | 18.27% |
| 3 | Consumer Discretionary | 11.28% |
| 4 | Financials | 10.55% |
| 5 | Industrials | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Dover
DOV
$28.4B
| $33.8M | 0.12% |
249,844
+149,099
| +148% | +$19.8M |
|
202
Waters Corp
WAT
$40.5B
| $33.5M | 0.12% |
97,734
+5,583
| +6% | +$1.77M |
|
203
Mondelez International
MDLZ
$78.1B
| $33.5M | 0.12% |
502,039
-189,145
| -27% | -$12M |
|
204
Omnicom Group
OMC
$23.1B
| $33.4M | 0.12% |
409,062
+29,592
| +8% | +$2.2M |
|
205
Consolidated Edison
ED
$39.3B
| $33.3M | 0.12% |
349,243
-20,757
| -6% | -$1.89M |
|
206
LKQ Corp
LKQ
$6.18B
| $33.3M | 0.12% |
623,112
+295,394
| +90% | +$15.6M |
|
207
BioCryst Pharmaceuticals
BCRX
$2.49B
| $32.9M | 0.12% |
2,862,387
+581,434
| +25% | +$7.25M |
|
208
MarketAxess Holdings
MKTX
$5.72B
| $32.5M | 0.12% |
116,357
+74,012
| +175% | +$19M |
|
209
Humana
HUM
$46.2B
| $32.3M | 0.12% |
63,129
-7,926
| -11% | -$4.17M |
|
210
Sherwin-Williams
SHW
$87.9B
| $32.2M | 0.12% |
135,816
+88,313
| +186% | +$20.4M |
|
211
Polestar Automotive Holding UK
PSNY
$2B
| $32.1M | 0.11% |
201,263
+56,278
| +39% | +$9.11M |
|
212
Idexx Laboratories
IDXX
$47.1B
| $31.1M | 0.11% |
76,242
-43,094
| -36% | -$16.7M |
|
213
Cummins
CMI
$87.9B
| $31M | 0.11% |
127,855
-18,968
| -13% | -$4.51M |
|
214
Vericel Corp
VCEL
$2.26B
| $30.9M | 0.11% |
1,174,352
+89,449
| +8% | +$2.13M |
|
215
QuantumScape Corp
QS
$3.77B
| $30.7M | 0.11% |
5,415,453
+1,712,958
| +46% | +$12.7M |
|
216
SLB Ltd
SLB
$78.9B
| $30.7M | 0.11% |
574,175
-59,543
| -9% | -$2.96M |
|
|
SILK
217
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $30.5M | 0.11% |
577,732
+17,169
| +3% | +$836K |
|
218
Rapid7
RPD
$768M
| $30.3M | 0.11% |
891,062
+177,467
| +25% | +$6.34M |
|
|
SGEN
219
DELISTED
Seagen Inc. Common Stock
SGEN
| $30.2M | 0.11% |
235,233
+129,642
| +123% | +$16.7M |
|
220
Alnylam Pharmaceuticals
ALNY
$28.9B
| $30.1M | 0.11% |
126,847
+61,583
| +94% | +$13.1M |
|
221
CBRE Group
CBRE
$41.8B
| $30.1M | 0.11% |
390,964
+54,133
| +16% | +$4M |
|
222
International Flavors & Fragrances
IFF
$21.6B
| $30M | 0.11% |
286,569
+77,728
| +37% | +$7.64M |
|
223
Infosys
INFY
$51B
| $30M | 0.11% |
1,663,754
-254,659
| -13% | -$4.74M |
|
|
AXNX
224
DELISTED
Axonics, Inc. Common Stock
AXNX
| $29.7M | 0.11% |
475,601
+50,382
| +12% | +$3.34M |
|
225
PureCycle Technologies
PCT
$1.44B
| $29.7M | 0.11% |
4,387,902
+275,900
| +7% | +$1.99M |
|
Similar funds
BNP Paribas Asset Management's Q4 2022 Portfolio in Review
As of Q4 2022, BNP Paribas Asset Management held 944 positions worth $27.9B, up 10% from $25.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
BNP Paribas Asset Management deployed $1.35B of net new capital in Q4 2022, opening 47 new positions and adding to 467 existing holdings. Its largest new stake was Tandem Diabetes Care: 367,548 shares worth $16.5M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Adobe, an estimated $114M trimmed.
- BNP Paribas Asset Management's largest Q4 2022 buy was Tandem Diabetes Care: 367,548 shares worth $16.5M.
- BNP Paribas Asset Management added most to Microsoft in Q4 2022, an estimated $199M increase.
- BNP Paribas Asset Management's biggest Q4 2022 reduction was Adobe, cutting an estimated $114M.
- BNP Paribas Asset Management fully exited Premier in Q4 2022, selling an estimated $33.2M.
- BNP Paribas Asset Management's ten largest holdings make up 20% of its $27.9B portfolio in Q4 2022.
- BNP Paribas Asset Management opened 47 new positions and closed 35 in Q4 2022.
- BNP Paribas Asset Management's portfolio value rose 10% quarter-over-quarter to $27.9B.
Based on BNP Paribas Asset Management's 13F filing for Q4 2022, filed 10 Feb 2023.